Application Sponsors
ANDA 076869 | ACTAVIS LABS FL INC | |
Marketing Status
Application Products
001 | TABLET, EXTENDED RELEASE;ORAL | 750MG | 0 | METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 2005-04-12 | |
LABELING; Labeling | SUPPL | 4 | AP | 2007-05-25 | |
LABELING; Labeling | SUPPL | 11 | AP | 2008-10-31 | |
LABELING; Labeling | SUPPL | 24 | AP | 2019-02-26 | STANDARD |
LABELING; Labeling | SUPPL | 26 | AP | 2019-02-26 | STANDARD |
Submissions Property Types
SUPPL | 24 | Null | 15 |
SUPPL | 26 | Null | 15 |
TE Codes
CDER Filings
ACTAVIS LABS FL INC
cder:Array
(
[0] => Array
(
[ApplNo] => 76869
[companyName] => ACTAVIS LABS FL INC
[docInserts] => ["",""]
[products] => [{"drugName":"METFORMIN HYDROCHLORIDE","activeIngredients":"METFORMIN HYDROCHLORIDE","strength":"750MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"METFORMIN HYDROCHLORIDE","submission":"METFORMIN HYDROCHLORIDE","actionType":"750MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)